153 related articles for article (PubMed ID: 6628536)
1. The effect of opioid drugs on the release of dopamine and 5-hydroxytryptamine from rat striatum following activation of nicotinic-cholinergic receptors.
Westfall TC; Grant H; Naes L; Meldrum M
Eur J Pharmacol; 1983 Aug; 92(1-2):35-42. PubMed ID: 6628536
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic system mediates only delta-opiate inhibition of endogenous acetylcholine release evoked by glutamate from rat striatal slices.
Arenas E; Alberch J; Marsal J
Neuroscience; 1991; 42(3):707-14. PubMed ID: 1683474
[TBL] [Abstract][Full Text] [Related]
3. Release of dopamine and 5-hydroxytryptamine from rat striatal slices following activation of nicotinic cholinergic receptors.
Westfall TC; Grant H; Perry H
Gen Pharmacol; 1983; 14(3):321-5. PubMed ID: 6135645
[TBL] [Abstract][Full Text] [Related]
4. The nicotinic-induced release of endogenous dopamine from rat striatal slices from animals chronically exposed to dimethylphenylpiperazinium (DMPP).
Westfall TC; Perry H
Neurosci Lett; 1986 Nov; 71(3):340-4. PubMed ID: 3796891
[TBL] [Abstract][Full Text] [Related]
5. Regional release of [3H]dopamine from rat brain in vitro: effects of opioids on release induced by potassium, nicotine, and L-glutamic acid.
Marien M; Brien J; Jhamandas K
Can J Physiol Pharmacol; 1983 Jan; 61(1):43-60. PubMed ID: 6132674
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of dopamine synthesis and release by morphine and D-ala2-D-leu5-enkephalin in the mouse striatum in vivo.
Urwyler S; Tabakoff B
Life Sci; 1981 May; 28(20):2277-86. PubMed ID: 6114377
[No Abstract] [Full Text] [Related]
7. Modulation of dopamine release in rat striatal slices by delta opiate agonists.
Lubetzki C; Chesselet MF; Glowinski J
J Pharmacol Exp Ther; 1982 Aug; 222(2):435-40. PubMed ID: 6284911
[TBL] [Abstract][Full Text] [Related]
8. Selective effects of [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 and [D-Ser2(O-t-butyl),Leu5]enkephalyl-Thr6 (O-t-butyl), two new enkephalin analogues, on neurotransmitter release and adenylate cyclase in rat brain slices.
De Vries TJ; Schoffelmeer AN; Delay-Goyet P; Roques BP; Mulder AH
Eur J Pharmacol; 1989 Nov; 170(3):137-43. PubMed ID: 2575993
[TBL] [Abstract][Full Text] [Related]
9. Effect of [D-Ala2,Met5]enkephalinamide and [D-Ala2,D-Leu5]enkephalin on cholinergic and noradrenergic neurotransmission in isolated atria.
Wong-Dusting HK; Rand MJ
Eur J Pharmacol; 1985 Apr; 111(1):65-72. PubMed ID: 2990945
[TBL] [Abstract][Full Text] [Related]
10. Chronic administration of morphine and naltrexone up-regulate[3H][D-Ala2,D-leu5]enkephalin binding sites by different mechanisms.
Danks JA; Tortella FC; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW; Rothman RB
Neuropharmacology; 1988 Sep; 27(9):965-74. PubMed ID: 2847072
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
12. Enkephalins have a direct positive inotropic effect on cultured cardiac myocytes.
Laurent S; Marsh JD; Smith TW
Proc Natl Acad Sci U S A; 1985 Sep; 82(17):5930-4. PubMed ID: 2994054
[TBL] [Abstract][Full Text] [Related]
13. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
Jhamandas K; Sutak M
Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
[TBL] [Abstract][Full Text] [Related]
14. [Cys(O2NH2)2]enkephalin analogues and dalargin: selectivity for delta-opioid receptors.
Pencheva N; Bocheva A; Dimitrov E; Ivancheva C; Radomirov R
Eur J Pharmacol; 1996 May; 304(1-3):99-108. PubMed ID: 8813590
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of dopamine-stimulated cyclic AMP efflux from rat neostriatal slices by activation of mu- and delta-opioid receptors: a permissive role for D-2 dopamine receptors.
Schoffelmeer AN; Hansen HA; Stoof JC; Mulder AH
Eur J Pharmacol; 1985 Dec; 118(3):363-6. PubMed ID: 2417870
[TBL] [Abstract][Full Text] [Related]
16. Classification of multiple morphine and enkephalin binding sites in the central nervous system.
Wolozin BL; Pasternak GW
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6181-5. PubMed ID: 6273857
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
Nishimura SL; Recht LD; Pasternak GW
Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950
[TBL] [Abstract][Full Text] [Related]
18. Effect of opioids on acetylcholine release evoked by K+ or glutamic acid from rat neostriatal slices.
Arenas E; Alberch J; Sanchez Arroyos R; Marsal J
Brain Res; 1990 Jul; 523(1):51-6. PubMed ID: 1976420
[TBL] [Abstract][Full Text] [Related]
19. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs.
Werling LL; Frattali A; Portoghese PS; Takemori AE; Cox BM
J Pharmacol Exp Ther; 1988 Jul; 246(1):282-6. PubMed ID: 2839666
[TBL] [Abstract][Full Text] [Related]
20. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
